Moderna COVID-19 vaccine

RNA COVID-19 vaccine

Moderna COVID-19 vaccine ▸ Facts ▸ Comments ▸ News ▸ Videos

The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in humans aged six months, twelve years, or eighteen years and older. It provides protection against COVID-19, which is caused by infection by the SARS-CoV-2 virus.

1 shares	Share Tweet Save Post Send

You Might Like

Moderna sues Pfizer/BioNTech over COVID vaccine Moderna is suing Pfizer and its German partner BioNTech for alleged patent infringement in the development of the first COVID-19 vaccine approved in the US. Sky News - Published on August 26, 2022
Indian Covid vaccines better than Pfizer, Moderna: Adar Poonawalla Serum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and.. IndiaTimes - Published on April 13, 2022
Pfizer and Moderna jabs give best overall boost, UK study finds The Pfizer and Moderna vaccines being used in the UK as boosters prompt the best overall response, according to a UK trial. Sky News - Published on December 3, 2021